Navigation Links
Georgia Stem Cell Initiative meets on MCG campus Feb. 10
Date:2/3/2009

AUGUSTA, Ga. The Georgia Stem Cell Initiative, a partnership of academia, industry and public officials to advance stem cell research in the state and educate the public about its impact, will meet Feb. 10 on the campus of the Medical College of Georgia.

The free daylong symposium is open to the public and designed to give participants an overview of the clinical potential of stem cells in areas such as stroke, heart attack and pediatric brain injury, says Dr. William D. Hill, neuroscientist in the MCG Schools of Medicine and Graduate Studies and meeting organizer.

"We want to build synergy among Georgia's already strong stem cell programs," Dr. Hill says of the dynamic field with broad therapeutic potential. That includes bringing together research universities, such as the University of Georgia and the Georgia Institute of Technology, with academic medical centers, such as MCG and Emory University, that can carry out clinical trials. As examples, UGA's Steve Dalton recently began collaborating with Dr. Hill and other MCG scientists in studies of the potential for stem cells to enhance stroke recovery and other conditions.

MCG researchers also will be working with UGA scientists and others to develop lines of induced multipotent cells that result from reprogramming of adult cells. In late 2007, researchers from the University of Wisconsin-Madison, Japan's Kyoto University and Harvard Medical School began sharing their success at turning adult cells into the embryonic-like cells with the potential to become many tissue types.

This is the third meeting of the Georgia Stem Cell Initiative, which formed in 2007 and currently has 125 members who are faculty or trainees at Georgia institutions.

Preregistration is requested at http://www.mcg.edu/som/cba/gsci/ for the event that begins with breakfast at 9 a.m. on the first floor of MCG's Health Sciences Building, off Laney-Walker Boulevard near the R.A. Dent Boulevard intersection. Dr. Frank Treiber, MCG vice president for research development, will welcome participants at 10 a.m.

Speakers and topics include:

  • 10:05 a.m. - Dr. Robert K. Yu, director of the MCG Institute of Molecular Medicine and Science, Neuroscience Institute and Cord Blood bank, "Research Utilization of the MCG Cord Blood Bank."

  • 10:15 a.m. - Dr. David C. Hess, chair of the MCG Department of Neurology and co-director of the Brain & Behavior Discovery Institute, "Potential Clinical Applications of Stem Cells in Stroke Injury."

  • 10:30 a.m. - Dr. Charles S. Cox, pediatric surgeon and adjoint professor, Department of Biomedical Engineering, University of Texas-Houston Medical Center, "Progenitor Cell Therapy for Traumatic Brain Injury."

  • 11:15 a.m. - Dr. Anthony Ting, director of Regenerative Medicine, Athersys Inc., "Acute Myocardial Infarction Phase 1 Clinical Trial of Allogenic Stem Cells."

  • Noon - Faculty and students are encouraged to present posters on stem-cell related research during lunch. Posters will be displayed in the main hall of the first floor of the Health Sciences Building.

  • 1:30 p.m. Dr. Carlos M. Isales, director of the regenerative medicine program, MCG Institute of Molecular Medicine and Genetics, will give an overview of his program.

  • 1:45 p.m. - Dr. Steve Dalton, associate professor, biochemistry and molecular biology, UGA Center for Drug Discovery, "Multipotent Cardiovascular Progenitors."

  • 2:15 p.m. - Dr. Erhard Bieberich, biochemist in the MCG Schools of Medicine and Graduate Studies, "Smart Drugs for Smarter Stem Cells Using Sphingolipids to Enhance Stem Cell Differentiation."

  • 2:45 p.m. - Dr. Dave Machacek, researcher, UGA College of Agriculture and Environmental Sciences, "Development of Ion Channel and Ionotropic Receptor Expression in Human Embryonic Stem Cell Derived Neural Cultures."

  • 3:15 p.m. Rich Carpenedo, graduate research assistant, Georgia Tech, "Engineering Stem Cell Technologies."

  • 3:45 p.m. - Roundtable discussion on how the Georgia Stem Cell Initiative can improve the efficiency of translating scientific discoveries into better care for patients.


'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
Source:Eurekalert

Related biology news :

1. MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR
2. Flu vaccine in painless skin patches under development at Emory, Georgia Tech with NIH grants
3. Georgia Tech/Emory Center to study origin of life
4. Tropical crab invades Georgia oyster reefs -- but the long-term impact cant be predicted
5. Stanford launches $100 million initiative to tackle energy issues
6. EPA and USDA should create new initiative to better monitor nutrients
7. NAS announces initiative to connect entertainment industry with top experts
8. Latin American Science Initiative Puts Tropical Rainforest Diversity Online
9. Global Viral Forecasting Initiative receives $11M to implement pandemic early warning system
10. NIHs Genes, Environment and Health Initiative adds 6 studies
11. Penn announces $50M Penn Integrates Knowledge neurosciences initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/9/2016)... 9, 2016 Paris Police ... video security solution to ensure the safety of people and ... during the major tournament Teleste, an international technology ... services, announced today that its video security solution will be ... back up public safety across the country. The system roll-out ...
(Date:6/2/2016)... June 2, 2016 The Department of ... awarded the 44 million US Dollar project, for the ... Plates including Personalization, Enrolment, and IT Infrastructure , ... the production and implementation of Identity Management Solutions. Numerous renowned ... Decatur was selected for the most ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" ... by its major shareholders, Clean Technology Fund I, LP ... States based venture capital funds which together ... (on a fully diluted, as converted basis), that they ... their entire equity holdings in Biorem to TUS Holdings ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the ... today the Clinical Reach Virtual Patient Encounter CONSULT module which enables both ... physician and clinical trial team. , Using the CONSULT module, patients and physicians can ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
Breaking Biology Technology: